InvestorsHub Logo

starkd748

08/20/20 4:50 PM

#893 RE: Boneride #892

160s tomorrow

jerrybrockman

08/20/20 8:20 PM

#895 RE: Boneride #892

That Mitsubishi feasibility study is a serious WILD card along with all the other big pharma cos sniffing around. I remember CAPR issuing a bs pr about Covid patients walking out of intensive care...it shot from 2.58 to 11 before they had to retract the story because one died. Same SS but this one is a lot different in many ways, all good. They definitely will not issue phony PR. Lo is an experienced pro, clearly knows what he is doing. He will only drop real news. If and when it hits, it will give ZSAN staying power at the next level.